Impact of renal artery stenosis on renovascular hypertension and the therapeutic role of renal artery stenting: a comprehensive review

医学 肾血管性高血压 肾动脉狭窄 心脏病学 内科学 肾动脉 血压 血运重建 继发性高血压 肾动脉阻塞 冠状动脉疾病 肾 心肌梗塞
作者
Changgang Shao,Guoqing Chi,Fang Li,Hongcheng Ren,Liyan Zhang,Jin‐Ming Yang,Bin Wang,Mingchao Ding
出处
期刊:Kidney & Blood Pressure Research [Karger Publishers]
卷期号:: 1-15 被引量:1
标识
DOI:10.1159/000545135
摘要

Background Renal artery stenosis (RAS) is characterized by reduced renal perfusion, activating the renin-angiotensin-aldosterone system (RAAS), which can lead to secondary hypertension, ischemic nephropathy, and cardiac destabilization syndrome. These conditions have significant healthcare implications. Renovascular hypertension (RVH) in RAS patients can be managed through medical therapy and revascularization, either endovascular or surgical. While renal artery stenting (RAS) was once viewed as the most effective treatment for atherosclerotic renovascular disease, recent trials suggest no significant difference in RVH management between medical therapy alone and combined with renal artery stenting. However, certain subgroups have exhibited favorable outcomes in blood pressure control post-stenting. Summary This comprehensive review synthesizes data, including findings from the HERCULES trial, which showed a reduction in blood pressure from 162.3±18.5/77.7±11.5 mmHg to 145.7±20.7/75.4±11.0 mmHg over 36 months (P<0.0001). Additionally, the ASPIRE-2 study demonstrated significant decreases in blood pressures from 168±25/82±13 mmHg to 149±25/77±12 mmHg at 24 months (P<0.001). The review delves into the prevalence, pathophysiology, clinical manifestations, diagnosis, and treatment of RAS-related RVH, specifically analyzing the efficacy and safety of renal artery stenting. Key Messages The analysis indicates that renal artery stenting may be particularly advantageous for certain patient subgroups, enhancing blood pressure outcomes and overall clinical status. Nevertheless, the criteria for selecting candidates for this intervention remain under debate. Future research should focus on high-risk RAS patients to explore long-term benefits and refine the utilization of renal artery stents, ultimately improving RVH management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
飞翔发布了新的文献求助10
刚刚
hyo发布了新的文献求助10
2秒前
Xinghe完成签到 ,获得积分10
2秒前
余子文发布了新的文献求助10
3秒前
3秒前
3秒前
xin驳回了酷波er的应助
3秒前
火星上的怀梦完成签到,获得积分10
3秒前
3秒前
华仔的应助被itsdeva采纳,获得10
4秒前
4秒前
研友_VZG7GZ的应助被loiter采纳,获得30
5秒前
5秒前
NexusExplorer的应助被开心德地采纳,获得10
5秒前
5秒前
情怀的应助被Lucky采纳,获得10
6秒前
wjw发布了新的文献求助10
6秒前
ssswww完成签到,获得积分20
7秒前
estate发布了新的文献求助20
7秒前
Jasper的应助被搞怪的乐荷采纳,获得10
7秒前
7秒前
7秒前
顾矜的应助被郭娅楠采纳,获得10
7秒前
wanci的应助被余子文采纳,获得10
7秒前
7秒前
阿紫吖完成签到,获得积分10
8秒前
搜集达人的应助被wg采纳,获得10
8秒前
8秒前
Nota发布了新的文献求助50
9秒前
likang发布了新的文献求助10
10秒前
老马完成签到,获得积分20
10秒前
Join发布了新的文献求助10
10秒前
ncjyl发布了新的文献求助10
10秒前
11秒前
无私的沁发布了新的文献求助10
11秒前
今后的应助被小张同学采纳,获得10
11秒前
风吹麦浪的应助被小张同学采纳,获得10
11秒前
小恶魔完成签到 ,获得积分10
13秒前
呆呆鱼完成签到 ,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188916
求助须知:如何正确求助?哪些是违规求助? 9576493
关于积分的说明 21848018
捐赠科研通 7786982
什么是DOI,文献DOI怎么找? 3435461
关于科研通互助平台的介绍 2559689
邀请新用户注册赠送积分活动 2482383